Improvement of patient-reported pain and functionality warrants future research. The homologous-use application validated by Dr. Parker sets a precedent for… Read More >
Dr. Speer is donating his time and expertise by applying Wharton’s Jelly allografts to qualifying veterans. Tuesday, October 31, 2023,… Read More >
The homologous-use application validated by Dr. Ryan Robinson and NP Rachel Reynolds sets a precedent for non-surgical allograft application. Thursday,… Read More >
PENSACOLA, Fla. , Feb. 27, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, is partnering with Brothers in Arms Foundation (BIAF), a… Read More >
Tyler Barrett has served as Chief Executive Officer of Regenative Labs for the past three years. With extensive experience as… Read More >
PENSACOLA, Fla., May 30, 2023 /PRNewswire/ — Regenative Labs (Regenative), a leading HCT/P manufacturer, announces one of its observational study… Read More >
Study approved by institutional review board of the Institute of Regenerative and Cellular Medicine. April 24, 2023—Regenative Labs (Regenative), a… Read More >
April 10, 2023, Pensacola, FL— Regenative Labs (Regenative), a leading provider of regenerative medicine solutions, announced that it will present… Read More >
March 9, 2023, Pensacola, FL—Regenative Labs (Regenative), a leading HCT/P manufacturer, is pleased to announce the publication of its new… Read More >
New data demonstrates statistically significant reported WOMAC improvement. February 20, 2023, Pensacola, FL – Regenative Labs (Regenative), a leading HCT/P… Read More >